Tinkerine Studios provides 3D Printing Services for Medical Devices in short supply due to COVID-19 Pandemic
March 20, 2020 - TheNewswire - Tinkerine(TM) Studios Ltd. (TSXV:TTD) ("Tinkerine" or the "Company") announces the launch of 3D printing services to the medical community to produce medical products currently in short supply due to the COVID-19 pandemic. Tinkerine maintains an inventory of DittoPro-R and DittoPro 3D printers that can be utilized to print products including face shields, ventilator valves, and breathing filters. Tinkerine is prepared and ready to provide required solutions for the medical community and sector in the weeks and months ahead. Tinkerine currently is designing a face shield that can be deployed to our nations front line workers.
Tinkerine is also offering up Applied Design services for additional medical devices potentially in short supply. In order to expedite design and manufacturing, Tinkerine requests the following information in order to begin production.
1.Email image (top / front / right) or .stl file to Tinkerine at email@example.com;
2.Provide any design or autocad files defining the product (if possible);
3.Provide quantity of product required;
4.Detailed contact information for Applied Design discussion and delivery.
Tinkerine also has 3D printers available for purchase by regional health authorities and government agencies.
Our mission is to provide a foundational understanding about Applied Design driven by 3D printing. Our ecosystem of 3D printing products and educational resources equips future generations with the innovative tools and products to stay ahead in a fast-paced, tech-driven world. Tinkerine enables the curious to convert creative ideas into the tangible and the unimaginable. All Tinkerine 3D printers and education services are designed and manufactured in Canada.
For further information please contact:
T: 403 617 7609
Chief Executive Officer
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.